Kary Eldred Galectin Therapeutics Inc (GALT) insider trading activity

Kary Eldred is of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 64,682 shares of GALT, which is worth approximately $243,851. The most recent transaction as insider was on Jul 21, 2025, when has been sold 1,000 shares (Common Stock) at a price of $2.92 per share, resulting in proceeds of $2,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 64.7K

1.57% 3M change

30.11% 12M change

Total Value Held $243,851

KARY ELDRED Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2025	BUY Open market or private purchase	$2,920 $2.92 p/Share	1,000 Added 1.52%	64,682 Common Stock
Dec 24 2024	BUY Open market or private purchase	$11,044 $0.82 p/Share	13,469 Added 17.46%	63,682 Common Stock
Oct 23 2024	BUY Open market or private purchase	$1,300 $2.6 p/Share	500 Added 0.99%	50,213 Common Stock
Jan 16 2024	BUY Open market or private purchase	$956 $2.39 p/Share	400 Added 0.8%	49,713 Common Stock
Jan 16 2024	BUY Open market or private purchase	$895 $1.79 p/Share	500 Added 1.0%	49,313 Common Stock
Jul 19 2023	BUY Open market or private purchase	$2,860 $1.79 p/Share	1,598 Added 3.17%	48,813 Common Stock
Feb 21 2023	BUY Open market or private purchase	$1,590 $1.59 p/Share	1,000 Added 2.07%	47,215 Common Stock
Jan 25 2023	BUY Open market or private purchase	$1,443 $1.11 p/Share	1,300 Added 2.74%	46,215 Common Stock

Kary Eldred

Norcross, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Value

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

Operation

Value

Type

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT

Account